Yuflyma, A High Concentration and Citrate-free Adalimumab Biosimilar, Received FDA Approval for Treating Different Forms of Inflammatory Diseases.
Vinod Kumar RajanaSudha Madhavi PenumakaCevella SarithaVelayutham RavichandiranDebabrata MandalPublished in: Anti-inflammatory & anti-allergy agents in medicinal chemistry (2023)